NO20005479D0 - SPLA2-hemmende forbindelser til behandling av sykdom - Google Patents

SPLA2-hemmende forbindelser til behandling av sykdom

Info

Publication number
NO20005479D0
NO20005479D0 NO20005479A NO20005479A NO20005479D0 NO 20005479 D0 NO20005479 D0 NO 20005479D0 NO 20005479 A NO20005479 A NO 20005479A NO 20005479 A NO20005479 A NO 20005479A NO 20005479 D0 NO20005479 D0 NO 20005479D0
Authority
NO
Norway
Prior art keywords
disease
treatment
inhibitory compounds
spla2
spla2 inhibitory
Prior art date
Application number
NO20005479A
Other languages
English (en)
Other versions
NO20005479L (no
Inventor
William Louis Macias
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005479D0 publication Critical patent/NO20005479D0/no
Publication of NO20005479L publication Critical patent/NO20005479L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005479A 1998-05-01 2000-10-31 sPLA2-hemmende forbindelser til behandling av sykdom NO20005479L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8387498P 1998-05-01 1998-05-01
PCT/US1999/008654 WO1999057100A1 (en) 1998-05-01 1999-04-20 Spla2 inhibitor compounds for treatment of disease

Publications (2)

Publication Number Publication Date
NO20005479D0 true NO20005479D0 (no) 2000-10-31
NO20005479L NO20005479L (no) 2000-12-20

Family

ID=22181224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005479A NO20005479L (no) 1998-05-01 2000-10-31 sPLA2-hemmende forbindelser til behandling av sykdom

Country Status (20)

Country Link
US (1) US6340699B1 (no)
EP (1) EP1084108A4 (no)
JP (1) JP2002513783A (no)
KR (1) KR20010043190A (no)
CN (1) CN1299348A (no)
AU (1) AU3656299A (no)
BR (1) BR9910095A (no)
CA (1) CA2330856A1 (no)
CZ (1) CZ20004052A3 (no)
EA (1) EA200001140A1 (no)
HR (1) HRP20000739A2 (no)
HU (1) HUP0102243A2 (no)
ID (1) ID27153A (no)
IL (1) IL139019A0 (no)
NO (1) NO20005479L (no)
PL (1) PL343708A1 (no)
SK (1) SK16342000A3 (no)
TR (1) TR200003194T2 (no)
WO (1) WO1999057100A1 (no)
ZA (1) ZA200005563B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
WO2001055108A2 (en) * 2000-01-25 2001-08-02 Eli Lilly And Company Use of spl a2 inhibitors for the treatment of inflammation
JPWO2002000621A1 (ja) 2000-06-29 2004-04-22 塩野義製薬株式会社 Ｘ型ｓＰＬＡ２阻害作用を有する化合物
IL154029A0 (en) * 2000-07-24 2003-07-31 Dow Global Technologies Inc Thermoplastic superabsorbent polymer blend compositions and their preparation
CA2627353A1 (en) * 2005-11-03 2007-05-18 Ilypsa, Inc. Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
US20110009379A1 (en) * 2008-04-01 2011-01-13 Astellas Pharma Inc. Indolinone compound
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356919A (en) 1991-05-30 1994-10-18 G. D. Searle & Co. Leukotriene B4 synthesis inhibitors
DE4218096A1 (de) 1992-06-02 1993-12-09 Boehringer Mannheim Gmbh Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel
DE4323409A1 (de) 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
ZA952693B (en) * 1994-04-01 1996-09-30 Lilly Co Eli 1H-indole-3-Glyoxylamide sPLA2 inhibitors
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
NZ298145A (en) * 1994-12-29 1998-08-26 Yamanouchi Pharma Co Ltd Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament
PL332896A1 (en) 1996-10-30 1999-10-25 Lilly Co Eli Substituted tricyclic compounds
NZ506329A (en) * 1998-02-25 2004-01-30 Inst Genetics Llc Inhibitors of phospholipase enzymes

Also Published As

Publication number Publication date
JP2002513783A (ja) 2002-05-14
EA200001140A1 (ru) 2001-04-23
SK16342000A3 (sk) 2002-04-04
TR200003194T2 (tr) 2001-03-21
EP1084108A4 (en) 2005-01-12
ZA200005563B (en) 2002-01-10
HRP20000739A2 (en) 2001-10-31
PL343708A1 (en) 2001-08-27
BR9910095A (pt) 2000-12-26
KR20010043190A (ko) 2001-05-25
HUP0102243A2 (hu) 2001-10-28
ID27153A (id) 2001-03-08
NO20005479L (no) 2000-12-20
IL139019A0 (en) 2001-11-25
WO1999057100A1 (en) 1999-11-11
US6340699B1 (en) 2002-01-22
CN1299348A (zh) 2001-06-13
CA2330856A1 (en) 1999-11-11
EP1084108A1 (en) 2001-03-21
AU3656299A (en) 1999-11-23
CZ20004052A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
NO20021474L (no) Forbindelser for behandling av ischemi
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
DK0769947T3 (da) Indolinonforbindelser til behandling af sygdom
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
AU2001282873A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20022087L (no) Fremgangsmåte for behandling av diabetes
AU2001284645A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20010953D0 (no) En fremgangsmÕte for behandling av stafylokokkal sykdom
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20005479D0 (no) SPLA2-hemmende forbindelser til behandling av sykdom
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
NO307859B1 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
NO20011268D0 (no) Forbindelse til behandling av depresjon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application